Reuters logo
Merck KGaA lifts outlook on drugs, flat screen chemicals
November 15, 2012 / 6:06 AM / 5 years ago

Merck KGaA lifts outlook on drugs, flat screen chemicals

DARMSTADT, Nov 15 (Reuters) - Merck KGaA lifted its 2012 outlook on Thursday and beat expectations for third-quarter results on higher prices for a multiple sclerosis drug and strong demand for its chemicals for flat screens.

The German drugmaker now expects adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) this year of 2.90-2.95 billion euros ($3.7-$3.75 billion), the upper half of a previous range of 2.85-2.95 billion euros.

Third-quarter adjusted EBITDA rose 15.6 percent to 754 million euros, above a forecast for 740 million in a Reuters poll. Revenues also exceeded expectations.

$1 = 0.7856 euros Reporting by Ludwig Burger

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below